Medifast, Inc. (MED) has a MoatMap StockRank of 66/100 based on Quality (47/100), Value (48/100), and Momentum (55/100) factor scores. The current signal is BUY. Medifast is a weight loss and wellness company whose business model has been structurally disrupted by the rapid adoption of GLP-1 weight-loss medications. This is a broken business model.
Medifast, Inc. is the company behind the OPTAVIA health and wellness community, offering clinically proven weight management and healthy living products. The company's competitive moat is sustained by its unique, coach-led direct-selling model, which drives high customer retention and organic brand advocacy. It operates as a leading player in the personal wellness and weight-loss industry.
| Price | $12.18 |
| Market Cap | $146M |
| P/E (Forward) | -20.45 |
| Price/Book | 0.64 |
| Return on Equity | -9.8% |
| Return on Invested Capital | -6.9% |
| Debt/Equity | 8.14 |
| Gross Margin | 70.1% |
| Operating Margin | -7.2% |
| Revenue Growth | -34.3% |
| Free Cash Flow | $4M |
Medifast, Inc. operates in the Personal Services industry, part of the Consumer Cyclical sector (United States).